bedaquiline
Johnson & Johnson Offers Global Access by Not Enforcing Sirturo’s Tuberculosis Drug Secondary Patents
Anika Sharma
Johnson & Johnson has taken significant steps to improve access to its multidrug-resistant tuberculosis (MDR-TB) medication, Sirturo (bedaquiline), in low- ...
J&J cuts TB drug price by 55% after giving up patent rights
Anika Sharma
Just seven weeks after announcing its willingness to permit generic competition for the drug-resistant tuberculosis (TB) treatment Sirturo (bedaquiline) in ...
